DNA methylation changes in cervical cancers

Methods in Molecular Biology

Volumn 863, Issue , 2012, Pages 155-176

  Lu, Qiang ^a   Ma, Dehua ^a   Zhao, Shuping ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; DNA methylation; Histone modifications; Human papillomaviruses

Indexed keywords

HISTONE; ONCOPROTEIN;

ARTICLE; DNA METHYLATION; DNA REPAIR; FEMALE; GENE; GENETIC EPIGENESIS; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

DNA METHYLATION; DNA REPAIR; EPIGENESIS, GENETIC; FEMALE; GENES, CDC; GENES, TUMOR SUPPRESSOR; HISTONES; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

PAPILLOMAVIRIDAE;

EID: 84860007985     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-612-8_9     Document Type: Article

References (177)

1. Singh, M., Tyagi, S., Bhui, K., Prasad, S., and Shukla, Y. (2010) Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs 28, 216-224.
2. Cain, J.M., Ngan, H., Garland, S., and Wright, T. (2009) Control of cervical cancer: Women's options and rights. Int J Gynaecol Obstet 106, 141-143
3. Moore, D.H. (2006) Cervical cancer. Obstet Gynecol 107, 1152-1161.
4. Petignat, P. and Roy, M. (2007) Diagnosis and management of cervical cancer. BMJ 335, 765-768. (Pubitemid 47616102)
5. Cadron, I., Van Gorp, T., Amant, F., Leunen, K., Neven, P., and Vergote, I. (2007) Chemotherapy for recurrent cervical cancer. Gynecol Oncol 107, S113-S118. (Pubitemid 47496062)
6. Baylin, S.B., and Ohm, J.E. (2006) Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6, 107-116. (Pubitemid 43361543)
7. Egger, G., Liang, G., Aparicio, A., and Jones, P.A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463. (Pubitemid 38715140)
8. Jones, P.A. and Baylin, S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428. (Pubitemid 34587077)
9. Eguchi, K., Kanai, Y., Kobayashi, K., and Hirohashi, S. (1997) DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history. Cancer Res. 57, 4913-4915. (Pubitemid 27469002)
10. Kanai, Y., Ushijima, S., Ochiai, A., Eguchi, K., Hui, A., and Hirohashi, S. (1998) DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett 122, 135-141. (Pubitemid 28058628)
11. Arai, E., Kanai, Y., Ushijima, S., Fujimoto, H., Mukai, K., and Hirohashi, S. (2006) Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int J Cancer 119, 288-296.
12. Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T., and Hirohashi, S. (1996) Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn J Cancer Res. 87, 1210-1217.
13. Sova, P., Feng, Q., Geiss, G., Wood, T., Strauss, R., Rudolf, V., Lieber, A., and Kiviat, N. (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol. Biomarkers Prev. 15, 114-123
14. Narayan, G., Arias-Pulido, H., Koul, S., Vargas, H., Zhang, F.F., Villella, J., Schneider, A., Terry, M.B., Mansukhani, M., and Murty, V.V. (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol. Cancer 2, 24.
15. Feng, Q., Balasubramanian, A., Hawes, S.E., Toure, P., Sow, P.S., Dem, A., Dembele, B., Critchlow, C.W., Xi, L., Lu, H., et al. (2005a) Detection of hypermethylated genes in women with and without cervical neoplasia . J Natl. Cancer Inst. 97, 273-282. (Pubitemid 40310275)
16. Steenbergen, R.D., Kramer, D., Braakhuis, B.J., Stern, P.L., Verheijen, R.H., Meijer, C.J., and Snijders, P.J. (2004) TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl. Cancer Inst. 96 , 294-305. (Pubitemid 38256274)
17. zur Hausen, H. (1999) Papillomaviruses in human cancers. Proc Assoc Am Physicians 111, 581-587
18. Munoz, N., Bosch, F.X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K.V., Snijders, P.J., and Meijer, C.J. (2003) Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527. (Pubitemid 36159887)
19. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J., and Munoz, N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19. (Pubitemid 29406813)
20. Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Peto, J., Schiffman, M.H., Moreno, V., Kurman, R., and Shah, K.V. (1995). Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl. Cancer Inst. 87, 796-802.
21. Franco, E.L. (1996). Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am 23, 597-623. (Pubitemid 26282353)
22. Ho, G.Y., Burk, R.D., Klein, S., Kadish, A.S., Chang, C.J., Palan, P., Basu, J., Tachezy, R., Lewis, R., and Romney, S. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl. Cancer Inst. 87, 1365-1371.
23. Ho, G.Y., Bierman, R., Beardsley, L., Chang, C.J., and Burk, R.D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338, 423-428. (Pubitemid 28135669)
24. Ho, G.Y., Palan, P.R., Basu, J., Romney, S.L., Kadish, A.S., Mikhail, M., Wassertheil-Smoller, S., Runowicz, C., and Burk, R.D. (1998) Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78, 594-599. (Pubitemid 28507183)
25. Doorbar, J., Ely, S., Sterling, J., McLean, C., and Crawford, L. (1991) Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate fi lament network. Nature 352, 824-827. (Pubitemid 21912441)
26. Ueda, Y., Enomoto, T., Miyatake, T., Ozaki, K., Yoshizaki, T., Kanao, H., Ueno, Y., Nakashima, R., Shroyer, K.R., and Murata, Y. (2003) Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: Association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab Invest 83, 1517-1527. (Pubitemid 37267835)
27. Harris, C.P., Lu, X.Y., Narayan, G., Singh, B., Murty, V.V., and Rao, P.H. (2003). Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 36, 233-241. (Pubitemid 36158196)
28. Atkin, N.B. and Baker, M.C. (1997) DNA ploidy of cervical intraepithelial neoplasia (CIN). Cancer Genet Cytogenet 94, 151-152.
29. Lai, H.C., Lin, Y.W., Huang, T.H., Yan, P., Huang, R.L., Wang, H.C., Liu, J., Chan, M.W., Chu, T.Y., Sun, C.A. , et al. (2008) Identifi cation of novel DNA methylation markers in cervical cancer. Int J Cancer 123, 161-167. (Pubitemid 351705204)
30. Kalantari, M., Calleja-Macias, I.E., Tewari, D., Hagmar, B., Lie, K., Barrera-Saldana, H.A., Wiley, D.J., and Bernard, H.U. (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78, 12762-12772. (Pubitemid 39507784)
31. Turan, T., Kalantari, M., Calleja-Macias, I.E., Cubie, H.A., Cuschieri, K., Villa, L.L., Skomedal, H., Barrera-Saldana, H.A., and Bernard, H.U. (2006) Methylation of the human papillomavirus-18L1 gene: A biomarker of neoplastic progression? Virology 349, 175-183.
32. Badal, S., Badal, V., Calleja-Macias, I.E., Kalantari, M., Chuang, L.S., Li, B.F., and Bernard, H.U. (2004) The human papillomavirus-18 genome is effi ciently targeted by cellular DNA methylation. Virology 324, 483-492. (Pubitemid 38797864)
33. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M., and Issa, J.P. (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res. 72, 141-196. (Pubitemid 27435555)
34. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang, J.C. , et al. (2000) Aberrant CpG-island methylation has non-random and tumour-Type-specific patterns. Nat. Genet. 24, 132-138. (Pubitemid 30094712)
35. Li, E., Bestor, T.H. and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
36. Bird, A.P. and Wolffe, A.P. (1999) Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454. (Pubitemid 129746827)
37. Baylin, S.B. (2002) Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin Cancer Biol 12, 331-337.
38. Feinberg, A.P. and Tycko, B. (2004) The history of cancer epigenetics. Nat Rev Cancer 4, 143-153. (Pubitemid 38198742)
39. Underwood, S.M., Ramsay-Johnson, E., Dean, A., Russ, J., and Ivalis, R. (2009) Expanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and control. J Natl Black Nurses Assoc 20, 42-54.
40. Duenas-Gonzalez, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C., and Cervera, E. (2005) Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol. Cancer 4, 38.
41. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
42. Wyllie, A.H., Kerr, J.F., and Currie, A.R. (1980) Cell death: The signifi cance of apoptosis. Int Rev Cytol 68, 251-306. (Pubitemid 11219226)
43. Sen, S. and D'Incalci, M. (1992). Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307, 122-127.
44. Deiss, L.P., Feinstein, E., Berissi, H., Cohen, O., and Kimchi, A. (1995) Identifi cation of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes. Dev. 9, 15-30.
45. Cohen, O., Feinstein, E., and Kimchi, A. (1997) DAP-kinase is a Ca2+/calmodulindependent, cytoskeletal-Associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 16, 998-1008. (Pubitemid 27113179)
46. Inbal, B., Cohen, O., Polak-Charcon, S., Kopolovic, J., Vadai, E., Eisenbach, L., and Kimchi, A. (1997) DAP kinase links the control of apoptosis to metastasis. Nature 390, 180-184. (Pubitemid 27507988)
47. Dong, S.M., Kim, H.S., Rha, S.H., and Sidransky, D. (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 7, 1982-1986. (Pubitemid 32994835)
48. Kang, S., Kim, J.W., Kang, G.H., Lee, S., Park, N.H., Song, Y.S., Park, S.Y., Kang, S.B., and Lee, H.P. (2006) Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 118, 2168-2171.
49. Shivapurkar, N., Sherman, M.E., Stastny, V., Echebiri, C., Rader, J.S., Nayar, R., Bonfi glio, T.A., Gazdar, A.F., and Wang, S.S. (2007) Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 107, 549-553. (Pubitemid 350160871)
50. Wisman, G.B., Nijhuis, E.R., Hoque, M.O., Reesink-Peters, N., Koning, A.J., Volders, H.H., Buikema, H.J., Boezen, H.M., Hollema, H., Schuuring, E. , et al. (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119, 1908-1914. (Pubitemid 44356850)
51. Yang, H.J., Liu, V.W., Wang, Y., Chan, K.Y., Tsang, P.C., Khoo, U.S., Cheung, A.N., and Ngan, H.Y. (2004) Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 93, 435-440. (Pubitemid 38507614)
52. Henken, F.E., Wilting, S.M., Overmeer, R.M., van Rietschoten, J.G., Nygren, A.O., Errami, A., Schouten, J.P., Meijer, C.J., Snijders, P.J., and Steenbergen, R.D. (2007) Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 97, 1457-1464. (Pubitemid 350114795)
53. Vousden, K.H. (2000). p53: Death star. Cell 103, 691-694.
54. Harris, S.L. and Levine, A.J. (2005) The p53 pathway: Positive and negative feedback loops. Oncogene 24, 2899-2908. (Pubitemid 40638098)
55. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D., and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2, 305-316. (Pubitemid 128379271)
56. Zhu, J., Jiang, J., Zhou, W., and Chen, X. (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58, 5061-5065. (Pubitemid 28521161)
57. Widschwendter, A., Muller, H.M., Hubalek, M.M., Wiedemair, A., Fiegl, H., Goebel, G., Mueller-Holzner, E., Marth, C., and Widschwendter, M. (2004) Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecol Oncol 93, 407-416. (Pubitemid 38507610)
58. Snijders, P.J., van Duin, M., Walboomers, J.M., Steenbergen, R.D., Risse, E.K., Helmerhorst, T.J., Verheijen, R.H., and Meijer, C.J. (1998) Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: Strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res. 58, 3812-3818. (Pubitemid 28405635)
59. Nakano, K., Watney, E., and McDougall, J.K. (1998) Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol. 153, 857-864. (Pubitemid 28419038)
60. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M. (1998) Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58, 1558-1561. (Pubitemid 28193624)
61. Wisman, G.B., Knol, A.J., Helder, M.N., Krans, M., de Vries, E.G., Hollema, H., de Jong, S., and van der Zee, A.G. (2001) Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer. Int J Cancer 91, 658-664. (Pubitemid 32115261)
62. Guilleret, I. and Benhattar, J. (2003) Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 289, 326-334. (Pubitemid 37117418)
63. Widschwendter, A., Muller, H.M., Hubalek, M.M., Wiedemair, A., Fiegl, H., Goebel, G., Mueller-Holzner, E., Marth, C., and Widschwendter, M. (2004) Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecol Oncol 93, 407-416. (Pubitemid 38507610)
64. Szliszka, E. and Krol, W. (2011) The role of dietary polyphenols in tumor necrosis factorrelated apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention. Eur J Cancer Prev 20, 63-69.
65. Ashkenazi, A. and Dixit, V.M. (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11, 255-260. (Pubitemid 29164042)
66. Ozoren, N. and El-Deiry, W.S. (2003) Cell surface Death Receptor signaling in normal and cancer cells. Semin Cancer Biol 13, 135-147. (Pubitemid 36321814)
67. Shivapurkar, N., Toyooka, S., Toyooka, K.O., Reddy, J., Miyajima, K., Suzuki, M., Shigematsu, H., Takahashi, T., Parikh, G., Pass, H.I. , et al. (2004) Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 109, 786-792. (Pubitemid 38405630)
68. Nakashima, R., Fujita, M., Enomoto, T., Haba, T., Yoshino, K., Wada, H., Kurachi, H., Sasaki, M., Wakasa, K., Inoue, M. , et al. (1999) Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 80, 458-467. (Pubitemid 29213201)
69. Bressac-de Paillerets, B. (1994) [Discovery of a new gene frequently inactivated in human cancers: Protein p16, a cell cycle regulator]. Bull Cancer 81, 853-856. (Pubitemid 24326899)
70. Nuovo, G.J., Plaia, T.W., Belinsky, S.A., Baylin, S.B., and Herman, J.G. (1999) In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. U S A 96, 12754-12759. (Pubitemid 29513575)
71. Virmani, A.K., Muller, C., Rathi, A., Zoechbauer-Mueller, S., Mathis, M., and Gazdar, A.F. (2001).Aberrant methylation during cervical carcinogenesis. Clin. Cancer Res. 7, 584-589. (Pubitemid 32707982)
72. Lea, J.S., Coleman, R., Kurien, A., Schorge, J.O., Miller, D.S., Minna, J.D., and Muller, C.Y. (2004) Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am. J. Obstet Gynecol 190, 674-679. (Pubitemid 38406777)
73. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B., and Sidransky, D. (1995) 5 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1, 686-692.
74. Otterson, G.A., Khleif, S.N., Chen, W., Coxon, A.B., and Kaye, F.J. (1995) CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-Aza 2 deoxycytidine. Oncogene 11, 1211-1216.
75. Ishikawa, M., Fujii, T., Saito, M., Nindl, I., Ono, A., Kubushiro, K., Tsukazaki, K., Mukai, M., and Nozawa, S. (2006) Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 16, 347-353.
76. Donninger, H., Vos, M.D., and Clark, G.J. (2007) The RASSF1A tumor suppressor. J Cell Sci 120, 3163-3172. (Pubitemid 350018407)
77. Liu, L., Tommasi, S., Lee, D.H., Dammann, R., and Pfeifer, G.P. (2003) Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22, 8125-8136. (Pubitemid 37487303)
78. Vos, M.D., Martinez, A., Elam, C., Dallol, A., Taylor, B.J., Latif, F., and Clark, G.J. (2004) A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res. 64, 4244-4250. (Pubitemid 38802429)
79. Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., and White, M.A. (2002) The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell Biol. 22, 4309-4318. (Pubitemid 34556598)
80. Whang, Y.M., Kim, Y.H., Kim, J.S., and Yoo, Y.D. (2005) RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res. 65, 3682-3690. (Pubitemid 40616345)
81. Vos, M.D., Ellis, C.A., Bell, A., Birrer, M.J., and Clark, G.J. (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol. Chem. 275, 35669-35672.
82. Vos, M.D., Dallol, A., Eckfeld, K., Allen, N.P., Donninger, H., Hesson, L.B., Calvisi, D., Latif, F., and Clark, G.J. (2006) The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol. Chem. 281, 4557-4563. (Pubitemid 43847713)
83. Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J.K., Kolch, W., and O'Neill, E. (2007) RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27, 962-975. (Pubitemid 47495894)
84. Dallol, A., Agathanggelou, A., Tommasi, S., Pfeifer, G.P., Maher, E.R., and Latif, F. (2005) Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res. 65, 7653-7659. (Pubitemid 41297238)
85. Cohen, Y., Singer, G., Lavie, O., Dong, S.M., Beller, U., and Sidransky, D. (2003) The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin. Cancer Res. 9, 2981-2984. (Pubitemid 36993256)
86. Kuzmin, I., Liu, L., Dammann, R., Geil, L., Stanbridge, E.J., Wilczynski, S.P., Lerman, M.I., and Pfeifer, G.P. (2003) Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res. 63, 1888-1893. (Pubitemid 36460854)
87. Yu, M.Y., Tong, J.H., Chan, P.K., Lee, T.L., Chan, M.W., Chan, A.W., Lo, K.W., and To, K.F. (2003) Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 105, 204-209. (Pubitemid 36505322)
88. Kang, S., Kim, J.W., Kang, G.H., Park, N.H., Song, Y.S., Kang, S.B., and Lee, H.P. (2005) Polymorphism in folate- and methioninemetabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol 96, 173-180. (Pubitemid 39612433)
89. Kang, S., Kim, H.S., Seo, S.S., Park, S.Y., Sidransky, D., and Dong, S.M. (2007) Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Gynecol Oncol 105, 662-666. (Pubitemid 46734191)
90. Lai, H.C., Lin, Y.W., Chang, C.C., Wang, H.C., Chu, T.W., Yu, M.H., and Chu, T.Y. (2007) Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 104, 629-635.
91. Matsuda, Y., Schlange, T., Oakeley, E.J., Boulay, A., and Hynes, N.E. (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res. 11, R32.
92. Deng, Y.H., Pu, X.X., Huang, M.J., Xiao, J., Zhou, J.M., Lin, T.Y., and Lin, E.H. (2010) 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells. Chin J Cancer 29, 810-815.
93. Hamada, F. (2009). [Wnt signaling and cancer]. Kaibogaku Zasshi 84, 111-112.
94. Takigawa, Y. and Brown, A.M. (2008) Wnt signaling in liver cancer. Curr Drug Targets 9, 1013-1024.
95. Katoh, M. (2005). WNT/PCP signaling pathway and human cancer (review). Oncol Rep 14, 1583-1588.
96. Samowitz, W.S., Slattery, M.L., Sweeney, C., Herrick, J., Wolff, R.K., and Albertsen, H. (2007) APC mutations and other genetic and epigenetic changes in colon cancer. Mol. Cancer Res. 5, 165-170. (Pubitemid 46423997)
97. Sarrio, D., Moreno-Bueno, G., Hardisson, D., Sanchez-Estevez, C., Guo, M., Herman, J.G., Gamallo, C., Esteller, M., and Palacios, J. (2003) Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106, 208-215. (Pubitemid 36835173)
98. Yang, H.J., Liu, V.W., Wang, Y., Tsang, P.C., and Ngan, H.Y. (2006) Differential DNA methylation profi les in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 6, 212.
99. Lynch, E.D., Ostermeyer, E.A., Lee, M.K., Arena, J.F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P.M., Kvinnsland, S. , et al. (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet. 61, 1254-1260. (Pubitemid 28046900)
100. Li, L. and Ross, A.H. (2007). Why is PTEN an important tumor suppressor? J Cell Biochem 102, 1368-1374. (Pubitemid 350223940)
101. Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D.B., Perera, S., Roberts, T.M., and Sellers, W.R. (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U S A 96, 2110-2115. (Pubitemid 29117876)
102. Tamura, M., Gu, J., Takino, T., and Yamada, K.M. (1999). Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59, 442-449. (Pubitemid 29048881)
103. Li, D.M. and Sun, H. (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. U S A 95, 15406-15411. (Pubitemid 29018711)
104. Rhei, E., Kang, L., Bogomolniy, F., Federici, M.G., Borgen, P.I., and Boyd, J. (1997). Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57, 3657-3659. (Pubitemid 27381202)
105. Teng, D.H., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K.L., Vinson, V.L., Gumpper, K.L. , et al. (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221-5225. (Pubitemid 27516352)
106. Gustafson, K.S., Furth, E.E., Heitjan, D.F., Fansler, Z.B., and Clark, D.P. (2004) DNA methylation profi ling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: An approach that utilizes receiver-operating characteristic analysis. Cancer 102, 259-268. (Pubitemid 39097157)
107. Cheung, T.H., Lo, K.W., Yim, S.F., Chan, L.K., Heung, M.S., Chan, C.S., Cheung, A.Y., Chung, T.K., and Wong, Y.F. (2004) Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol 93, 621-627. (Pubitemid 38766045)
108. Pegg, A.E. and Byers, T.L. (1992) Repair of DNA containing O6-Alkylguanine. FASEB J 6, 2302-2310.
109. Jacinto, F.V. and Esteller, M. (2007) MGMT hypermethylation: A prognostic foe, a predictive friend. DNA Repair (Amst) 6, 1155-1160. (Pubitemid 47058396)
110. Esteller, M. and Herman, J.G. (2004) Generating mutations but providing chemosensitivity: The role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 23, 1-8. (Pubitemid 38142234)
111. Zochbauer-Muller, S., Fong, K.M., Virmani, A.K., Geradts, J., Gazdar, A.F., and Minna, J.D. (2001) Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61, 249-255. (Pubitemid 32095725)
112. Oh, K., Redston, M., and Odze, R.D. (2005) Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplasticadenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol 36, 101-111. (Pubitemid 40215639)
113. Preuss, I., Haas, S., Eichhorn, U., Eberhagen, I., Kaufmann, M., Beck, T., Eibl, R.H., Dall, P., Bauknecht, T., Hengstler, J. , et al. (1996) Activity of the DNA repair protein O6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue. Cancer Detect Prev 20, 130-136. (Pubitemid 3042345)
114. Hengstler, J.G., Tanner, B., Moller, L., Meinert, R., and Kaina, B. (1999) Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer. Int J Cancer 84, 388-395. (Pubitemid 29337125)
115. Margison, G.P., Povey, A.C., Kaina, B., and Santibanez Koref, M.F. (2003) Variability and regulation of O6-Alkylguanine-DNA alkyltransferase. Carcinogenesis 24, 625-635.
116. Zambrano, P., Segura-Pacheco, B., Perez-Cardenas, E., Cetina, L., Revilla-Vazquez, A., Taja-Chayeb, L., Chavez-Blanco, A., Angeles, E., Cabrera, G., Sandoval, K. , et al. (2005) A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 5, 44.
117. Narayan, G., Arias-Pulido, H., Nandula, S.V., Basso, K., Sugirtharaj, D.D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A. , et al. (2004) Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 64, 2994-2997. (Pubitemid 38581394)
118. Widschwendter, A., Gattringer, C., Ivarsson, L., Fiegl, H., Schneitter, A., Ramoni, A., Muller, H.M., Wiedemair, A., Jerabek, S., Muller-Holzner, E. , et al. (2004) Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin. Cancer Res. 10, 3396-3400. (Pubitemid 38685445)
119. Gumbiner, B.M. (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol. Cell Biol. 6, 622-634. (Pubitemid 41081266)
120. Koriyama, C., Akiba, S., Itoh, T., Sueyoshi, K., Minakami, Y., Corvalan, A., Yonezawa, S., and Eizuru, Y. (2007) E-cadherin and betacatenin expression in Epstein-Barr virus-Associated gastric carcinoma and their prognostic signifi cance. World J Gastroenterol 13, 3925-3931. (Pubitemid 47272487)
121. Branca, M., Giorgi, C., Ciotti, M., Santini, D., Di Bonito, L., Costa, S., Benedetto, A., Bonifacio, D., Di Bonito, P., Paba, P. , et al. (2006) Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer. Eur J Gynaecol Oncol 27, 215-223. (Pubitemid 43953413)
122. Cavallaro, U. and Christofori, G. (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4, 118-132. (Pubitemid 38198740)
123. Ren, C.C., Miao, X.H., Yang, B., Zhao, L., Sun, R., and Song, W.Q. (2006) Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients. Int J Gynecol Cancer 16, 1862-1867. (Pubitemid 44470047)
124. Widschwendter, A., Ivarsson, L., Blassnig, A., Muller, H.M., Fiegl, H., Wiedemair, A., Muller-Holzner, E., Goebel, G., Marth, C., and Widschwendter, M. (2004). CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer 109, 163-166. (Pubitemid 38240915)
125. Hendricks, D.T., Taylor, R., Reed, M., and Birrer, M.J. (1997) FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 57, 2112-2115. (Pubitemid 27247022)
126. Birrer, M.J., Hendricks, D., Farley, J., Sundborg, M.J., Bonome, T., Walts, M.J., and Geradts, J. (1999) Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res. 59, 5270-5274. (Pubitemid 29503993)
127. Tsao, I. and Atramentova, L.A. (2009) [Genetic and epigenetic changes of FHIT gene in patients with esophageal cancer]. Tsitol Genet 43, 40-44.
128. Pavelic, K., Krizanac, S., Cacev, T., Hadzija, M.P., Radosevic, S., Crnic, I., Levanat, S., and Kapitanovic, S. (2001) Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas. Mol Med 7, 442-453. (Pubitemid 33701965)
129. Wang, X., Yuan, L., Zheng, H., Liu, J., Huang, X., Wu, L., Yuan, H., and Zhao, J. (2009) [Expression of FHIT Protein in Lung Cancer by Cell Array.]. Zhongguo Fei Ai Za Zhi 12, 131-134.
130. Li, Y.Z. and Zhao, P. (2009). [Expressions of cyclinB1, FHIT and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic signifi cance]. Zhonghua Yi Xue Za Zhi 89, 2337-2341.
131. Syeed, N., Husain, S.A., Sameer, A.S., Chowdhri, N.A., and Siddiqi, M.A. (2011) Mutational and promoter hypermethylation status of FHIT gene in breast cancer patients of Kashmir. Mutat Res 707, 1-8.
132. Wu, Q., Shi, H., Suo, Z., and Nesland, J.M. (2003) 5 ¢ -CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas. Ultrastruct Pathol 27, 417-422. (Pubitemid 38041328)
133. Wistuba, II, Montellano, F.D., Milchgrub, S., Virmani, A.K., Behrens, C., Chen, H., Ahmadian, M., Nowak, J.A., Muller, C., Minna, J.D. , et al. (1997) Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 57, 3154-3158. (Pubitemid 27351729)
134. Larson, A.A., Kern, S., Curtiss, S., Gordon, R., Cavenee, W.K., and Hampton, G.M. (1997) High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res. 57, 4082-4090. (Pubitemid 27427701)
135. Widschwendter, M., Berger, J., Hermann, M., Muller, H.M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A.G., Daxenbichler, G. , et al. (2000) Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl. Cancer Inst. 92, 826-832. (Pubitemid 30368039)
136. Khan, M.A., Jenkins, G.R., Tolleson, W.H., Creek, K.E., and Pirisi, L. (1993) Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes. Cancer Res. 53, 905-909. (Pubitemid 23077882)
137. Meyskens, F.L., Jr., Surwit, E., Moon, T.E., Childers, J.M., Davis, J.R., Dorr, R.T., Johnson, C.S., and Alberts, D.S. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-Trans-retinoic acid: A randomized trial. J Natl. Cancer Inst. 86, 539-543.
138. Ivanova, T., Petrenko, A., Gritsko, T., Vinokourova, S., Eshilev, E., Kobzeva, V., Kisseljov, F., and Kisseljova, N. (2002) Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer 2, 4.
139. Pehlivan, S., Artac, M., Sever, T., Bozcuk, H., Kilincarslan, C., and Pehlivan, M. (2010). Gene methylation of SFRP2, P16, DAPK1, HIC1, and MGMT and KRAS mutations in sporadic colorectal cancer. Cancer Genet Cytogenet 201, 128-132.
140. Kekeeva, T.V., Popova, O.P., Shegai, P.V., Alekseev, B., Adnreeva, I., Zaletaev, D.V., and Nemtsova, M.V. (2007) [Abberant methylation of p16, HIC1, N33 and GSTP1 genes in tumor epithelium and tumor-Associated stromal cells of prostate cancer]. Mol Biol (Mosk) 41, 79-85.
141. Rathi, A., Virmani, A.K., Harada, K., Timmons, C.F., Miyajima, K., Hay, R.J., Mastrangelo, D., Maitra, A., Tomlinson, G.E., and Gazdar, A.F. (2003) Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. Clin. Cancer Res. 9, 3674-3678. (Pubitemid 37169234)
142. Chen, W.Y., Zeng, X., Carter, M.G., Morrell, C.N., Chiu Yen, R.W., Esteller, M., Watkins, D.N., Herman, J.G., Mankowski, J.L., and Baylin, S.B. (2003) Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 33 , 197-202. (Pubitemid 36177074)
143. Chen, W., Cooper, T.K., Zahnow, C.A., Overholtzer, M., Zhao, Z., Ladanyi, M., Karp, J.E., Gokgoz, N., Wunder, J.S., Andrulis, I.L. , et al. (2004) Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6, 387-398. (Pubitemid 39361439)
144. Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H.P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T. , et al. (2001) TSLC1 is a tumorsuppressor gene in human non-small-cell lung cancer. Nat. Genet. 27, 427-430. (Pubitemid 32268425)
145. Fukuhara, H., Kuramochi, M., Fukami, T., Kasahara, K., Furuhata, M., Nobukuni, T., Maruyama, T., Isogai, K., Sekiya, T., Shuin, T. , et al. (2002) Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res. 93, 605-609. (Pubitemid 34846267)
146. Allinen, M., Peri, L., Kujala, S., Lahti-Domenici, J., Outila, K., Karppinen, S.M., Launonen, V., and Winqvist, R. (2002) Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: Indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 34, 384-389. (Pubitemid 34787459)
147. Ito, T., Shimada, Y., Hashimoto, Y., Kaganoi, J., Kan, T., Watanabe, G., Murakami, Y., and Imamura, M. (2003) Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res. 63, 6320-6326. (Pubitemid 37255179)
148. Jansen, M., Fukushima, N., Rosty, C., Walter, K., Altink, R., Heek, T.V., Hruban, R., Offerhaus, J.G., and Goggins, M. (2002) Aberrant methylation of the 5 CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is fi rst manifest in highgrade PanlNs. Cancer Biol Ther 1, 293-296.
149. Watabe, K., Ito, A., Koma, Y.I., and Kitamura, Y. (2003) IGSF4: A new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function. Histol Histopathol 18, 1321-1329. (Pubitemid 37265032)
150. Li, J., Zhang, Z., Bidder, M., Funk, M.C., Nguyen, L., Goodfellow, P.J., and Rader, J.S. (2005) IGSF4 promoter methylation and expression silencing in human cervical cancer. Gynecol Oncol 96, 150-158. (Pubitemid 39612430)
151. Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S., and Yamamura, H. (1991) Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-Tyrosine kinase showing high susceptibility to proteolysis. J Biol. Chem. 266, 15790-15796. (Pubitemid 21907727)
152. Coopman, P.J., Do, M.T., Barth, M., Bowden, E.T., Hayes, A.J., Basyuk, E., Blancato, J.K., Vezza, P.R., McLeskey, S.W., Mangeat, P.H., et al. (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406, 742-747.
153. Ulanova, M., Puttagunta, L., Marcet-Palacios, M., Duszyk, M., Steinhoff, U., Duta, F., Kim, M.K., Indik, Z.K., Schreiber, A.D., and Befus, A.D. (2005) Syk tyrosine kinase participates in beta1-integrin signaling and infl ammatory responses in airway epithelial cells. Am. J. Physiol Lung Cell Mol Physiol 288, L497-507.
154. Yamada, T., Fujieda, S., Yanagi, S., Yamamura, H., Inatome, R., Sunaga, H., and Saito, H. (2001) Protein-Tyrosine kinase Syk expressed in human nasal fi broblasts and its effect on RANTES production. J Immunol 166, 538-543. (Pubitemid 32038474)
155. Inatome, R., Yanagi, S., Takano, T., and Yamamura, H. (2001) A critical role for Syk in endothelial cell proliferation and migration. Biochem Biophys Res Commun 286, 195-199. (Pubitemid 32917669)
156. Yuan, Y., Wang, J., Li, J., Wang, L., Li, M., Yang, Z., Zhang, C., and Dai, J.L. (2006) Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin. Cancer Res. 12, 6687-6695. (Pubitemid 44876836)
157. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J.P., and Tybulewicz, V.L. (2000) Tyrosine kinase SYK: Essential functions for immunoreceptor signalling. Immunol Today 21, 148-154. (Pubitemid 30122705)
158. Brumbaugh, K.M., Binstadt, B.A., Billadeau, D.D., Schoon, R.A., Dick, C.J., Ten, R.M., and Leibson, P.J. (1997) Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med 186, 1965-1974. (Pubitemid 28013680)
159. Yuan, Y., Mendez, R., Sahin, A., and Dai, J.L. (2001) Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res. 61, 5558-5561. (Pubitemid 32694942)
160. Toyama, T., Iwase, H., Yamashita, H., Hara, Y., Omoto, Y., Sugiura, H., Zhang, Z., and Fujii, Y. (2003) Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 189, 97-102. (Pubitemid 35351524)
161. Zhao, S., Sun, G., Tony, P.W., Ma, D., and Zhao, C. (2011) Expression and methylation status of the Syk gene in cervical carcinoma. Arch Gynecol Obstet. 283, 1113-1119.
162. Douc-Rasy, S., Barrois, M., Fogel, S., Ahomadegbe, J.C., Stehelin, D., Coll, J., and Riou, G. (1996) High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12, 423-430. (Pubitemid 26042578)
163. Gama-Sosa, M.A., Slagel, V.A., Trewyn, R.W., Oxenhandler, R., Kuo, K.C., Gehrke, C.W., and Ehrlich, M. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11, 6883-6894.
164. Kim, Y.I., Giuliano, A., Hatch, K.D., Schneider, A., Nour, M.A., Dallal, G.E., Selhub, J., and Mason, J.B. (1994) Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74, 893-899. (Pubitemid 24237470)
165. de Capoa, A., Musolino, A., Della Rosa, S., Caiafa, P., Mariani, L., Del Nonno, F., Vocaturo, A., Donnorso, R.P., Niveleau, A., and Grappelli, C. (2003) DNA demethylation is directly related to tumour progression: Evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol Rep 10, 545-549.
166. Mathers, J.C. (2008) Session 2: Personalised nutrition. Epigenomics: A basis for understanding individual differences? Proc Nutr Soc 67, 390-394.
167. Kristjuhan, A., Walker, J., Suka, N., Grunstein, M., Roberts, D., Cairns, B.R., and Svejstrup, J.Q. (2002) Transcriptional inhibition of genes with severe histone h3 hypoacetylation in the coding region. Mol Cell 10, 925-933. (Pubitemid 35335646)
168. Du, T.T. and Huang, Q.H. (2007) [The roles of histone lysine methylation in epigenetic regulation]. Yi Chuan 29, 387-392.
169. Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37, 391-400.
170. Anton, M., Horky, M., Kuchtickova, S., Vojtesek, B., and Blaha, O. (2004) Immunohistochemical detection of acetylation and phosphorylation of histone H3 in cervical smears. Ceska Gynekol 69, 3-6. (Pubitemid 38222323)
171. Pisani, P., Bray, F., and Parkin, D.M. (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97, 72-81.
172. Wang, S.S., Sherman, M.E., Hildesheim, A., Lacey, J.V., Jr., and Devesa, S. (2004) Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 100, 1035-1044. (Pubitemid 38232621)
173. Kulasingam, S.L., Hughes, J.P., Kiviat, N.B., Mao, C., Weiss, N.S., Kuypers, J.M., and Koutsky, L.A. (2002) Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specifi city, and frequency of referral. JAMA 288, 1749-1757.
174. Bulkmans, N.W., Berkhof, J., Bulk, S., Bleeker, M.C., van Kemenade, F.J., Rozendaal, L., Snijders, P.J., and Meijer, C.J. (2007) Highrisk HPV type-specific clearance rates in cervical screening. Br J Cancer 96, 1419-1424. (Pubitemid 46685773)
175. Nieh, S., Chen, S.F., Chu, T.Y., Lai, H.C., Lin, Y.S., Fu, E., and Gau, C.H. (2005) Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined signifi cance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 97, 35-40. (Pubitemid 40403671)
176. Kalof, A.N., Evans, M.F., Simmons-Arnold, L., Beatty, B.G., and Cooper, K. (2005) p16INK4A immunoexpression and HPV in situ hybridization signal patterns: Potential markers of high-grade cervical intraepithelial neoplasia. Am. J. Surg Pathol 29, 674-679. (Pubitemid 40577879)
177. Laird, P.W. (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3, 253-266. (Pubitemid 37328861)